{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T23:24:25Z","timestamp":1787181865888,"version":"build-2736575974"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003827","name":"National Research Development and Innovation Office","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003827","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.biopha.2026.119772","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T16:26:14Z","timestamp":1784910374000},"page":"119772","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Evaluating the cardiometabolic impact of Janus-kinase inhibition: An experimental analysis of Tofacitinib's therapeutic potential in a rodent model"],"prefix":"10.1016","volume":"202","author":[{"given":"Vera","family":"Tarj\u00e1nyi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Szil\u00e1gyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9ka","family":"Szekeres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Tak\u00e1cs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bal\u00e1zs","family":"Varga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e1niel","family":"Priksz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf","family":"Gesztelyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e1bor","family":"Viczj\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tam\u00e1s","family":"Erdei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panna","family":"G\u00f6r\u00f6gh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Kiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tymur","family":"Vietrov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Adeagbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Botond","family":"Ga\u00e1l","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gy\u00f6rgy","family":"Trencs\u00e9nyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attila","family":"Hamar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zolt\u00e1n","family":"Szilv\u00e1ssy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9la","family":"Juh\u00e1sz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariann","family":"Bombicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.biopha.2026.119772_bib1","first-page":"591","article-title":"Global epidemiology of rheumatoid arthritis","volume":"18","author":"Finckh","year":"2022","journal-title":"Nat. Rev. Rheumatol."},{"issue":"10","key":"10.1016\/j.biopha.2026.119772_bib2","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1093\/rheumatology\/kep252","article-title":"Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a systematic review and meta-analysis of cohort studies","volume":"48","author":"Meune","year":"2009","journal-title":"Rheumatol. (Oxf. )"},{"key":"10.1016\/j.biopha.2026.119772_bib3","doi-asserted-by":"crossref","first-page":"k1036","DOI":"10.1136\/bmj.k1036","article-title":"Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications","volume":"361","author":"England","year":"2018","journal-title":"BMJ"},{"issue":"11","key":"10.1016\/j.biopha.2026.119772_bib4","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/nrrheum.2014.121","article-title":"Rheumatoid arthritis and metabolic syndrome","volume":"10","author":"Kerekes","year":"2014","journal-title":"Nat. Rev. Rheumatol."},{"issue":"10","key":"10.1016\/j.biopha.2026.119772_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078151","article-title":"The risk of metabolic syndrome in patients with rheumatoid arthritis: a meta-analysis of observational studies","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS. One"},{"issue":"3","key":"10.1016\/j.biopha.2026.119772_bib6","doi-asserted-by":"crossref","first-page":"186","DOI":"10.3109\/03009742.2011.626443","article-title":"Metabolic syndrome prevalence is increased in rheumatoid arthritis patients and is associated with disease activity","volume":"41","author":"da Cunha","year":"2012","journal-title":"Scand. J. Rheumatol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119772_bib7","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.autrev.2008.05.001","article-title":"DMARDS and infections in rheumatoid arthritis","volume":"8","author":"Caporali","year":"2008","journal-title":"Autoimmun. Rev."},{"issue":"2","key":"10.1016\/j.biopha.2026.119772_bib8","doi-asserted-by":"crossref","first-page":"s57","DOI":"10.7861\/clinmed.20-2-s57","article-title":"Tocilizumab-induced pulmonary fibrosis in a patient with rheumatoid arthritis","volume":"20","author":"Silva","year":"2020","journal-title":"Clin. Med. (Lond. )"},{"issue":"1","key":"10.1016\/j.biopha.2026.119772_bib9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/ard-2022-223356","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update","volume":"82","author":"Smolen","year":"2023","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.biopha.2026.119772_bib10","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.semarthrit.2016.05.014","article-title":"Cardiovascular safety findings in patients with rheumatoid arthritis treated with tofacitinib, an oral Janus kinase inhibitor","volume":"46","author":"Charles-Schoeman","year":"2016","journal-title":"Semin. Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.biopha.2026.119772_bib11","doi-asserted-by":"crossref","DOI":"10.1186\/ar2765","article-title":"Methotrexate therapy associates with reduced prevalence of the metabolic syndrome in rheumatoid arthritis patients over the age of 60- more than just an anti-inflammatory effect? A cross sectional study","volume":"11","author":"Toms","year":"2009","journal-title":"Arthritis Res. Ther."},{"issue":"6","key":"10.1016\/j.biopha.2026.119772_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25063292","article-title":"Assessing the Impact of Influenza Vaccination Timing on Experimental Arthritis: Effects on Disease Progression and Inflammatory Biomarkers","volume":"25","author":"Tarj\u00e1nyi","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2026.119772_bib13","doi-asserted-by":"crossref","DOI":"10.1186\/ar2365","article-title":"Cartilage preservation by inhibition of Janus kinase 3 in two rodent models of rheumatoid arthritis","volume":"10","author":"Milici","year":"2008","journal-title":"Arthritis Res. Ther."},{"issue":"6","key":"10.1016\/j.biopha.2026.119772_bib14","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1002\/1529-0131(200006)43:6<1266::AID-ANR9>3.0.CO;2-P","article-title":"Temporal expression of inflammatory cytokines and chemokines in rat adjuvant-induced arthritis","volume":"43","author":"Szekanecz","year":"2000","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.biopha.2026.119772_bib15","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3389\/fnmol.2017.00284","article-title":"Methods Used to Evaluate Pain Behaviors in Rodents","volume":"10","author":"Deuis","year":"2017","journal-title":"Front. Mol. Neurosci."},{"issue":"1","key":"10.1016\/j.biopha.2026.119772_bib16","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","article-title":"Quantitative assessment of tactile allodynia in the rat paw","volume":"53","author":"Chaplan","year":"1994","journal-title":"J. Neurosci. Methods"},{"issue":"7","key":"10.1016\/j.biopha.2026.119772_bib17","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.biopha.2026.119772_bib18","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2337\/diab.37.3.321","article-title":"Measurement of rat insulin. Enzyme-linked immunosorbent assay with increased sensitivity, high accuracy, and greater practicability than established radioimmunoassay","volume":"37","author":"Kekow","year":"1988","journal-title":"Diabetes"},{"issue":"17","key":"10.1016\/j.biopha.2026.119772_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241713253","article-title":"Therapeutic Aspects of Prunus cerasus Extract in a Rabbit Model of Atherosclerosis-Associated Diastolic Dysfunction","volume":"24","author":"Szekeres","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2026.119772_bib20","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0304-3940(95)12180-3","article-title":"Species differences in the concentration of acetylcholine, a neurotransmitter, in whole blood and plasma","volume":"201","author":"Fujii","year":"1995","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.biopha.2026.119772_bib21","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.pathophys.2005.07.011","article-title":"Animal models of rheumatoid arthritis and their relevance to human disease","volume":"12","author":"Kannan","year":"2005","journal-title":"Pathophysiology"},{"issue":"5","key":"10.1016\/j.biopha.2026.119772_bib22","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jbspin.2015.10.016","article-title":"Metabolic syndrome is associated with disease activity in patients with rheumatoid arthritis","volume":"83","author":"Tantayakom","year":"2016","journal-title":"Jt. Bone Spine"},{"issue":"1","key":"10.1016\/j.biopha.2026.119772_bib23","doi-asserted-by":"crossref","first-page":"44","DOI":"10.4082\/kjfm.2016.37.1.44","article-title":"Relationship between Metabolic Syndrome and Rheumatoid Arthritis","volume":"37","author":"Lee","year":"2016","journal-title":"Korean J. Fam. Med."},{"key":"10.1016\/j.biopha.2026.119772_bib24","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2147\/DMSO.S15323","article-title":"TRC150094 attenuates progression of nontraditional cardiovascular risk factors associated with obesity and type 2 diabetes in obese ZSF1 rats","volume":"4","author":"Zambad","year":"2011","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"10.1016\/j.biopha.2026.119772_bib25","article-title":"Metabonomic Study on the Plasma of High-Fat Diet-Induced Dyslipidemia Rats Treated with Ge Gen Qin Lian Decoction by Ultrahigh-Performance Liquid Chromatography-Mass Spectrometry","volume":"2021","author":"Xu","year":"2021","journal-title":"Evid. Based Complement. Altern. Med."},{"issue":"10","key":"10.1016\/j.biopha.2026.119772_bib26","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/acr.23930","article-title":"Changes in Lipid Levels and Incidence of Cardiovascular Events Following Tofacitinib Treatment in Patients With Psoriatic Arthritis: A Pooled Analysis Across Phase III and Long-Term Extension Studies","volume":"71","author":"Gladman","year":"2019","journal-title":"Arthritis Care Res. (Hoboken)"},{"issue":"1","key":"10.1016\/j.biopha.2026.119772_bib27","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cgh.2019.04.059","article-title":"Tofacitinib Treatment Is Associated With Modest and Reversible Increases in Serum Lipids in Patients With Ulcerative Colitis","volume":"18","author":"Sands","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"3.4","key":"10.1016\/j.biopha.2026.119772_bib28","doi-asserted-by":"crossref","first-page":"166","DOI":"10.2152\/jmi.65.166","article-title":"Effect of Janus kinase inhibition by tofacitinib on body composition and glucose metabolism","volume":"65","author":"Chikugo","year":"2018","journal-title":"J. Med. Invest."},{"key":"10.1016\/j.biopha.2026.119772_bib29","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/710928","article-title":"Metabolic syndrome in rheumatoid arthritis","volume":"2013","author":"Ferraz-Amaro","year":"2013","journal-title":"Mediat. Inflamm."},{"issue":"2","key":"10.1016\/j.biopha.2026.119772_bib30","doi-asserted-by":"crossref","DOI":"10.1186\/ar2643","article-title":"Rheumatoid cachexia is associated with dyslipidemia and low levels of atheroprotective natural antibodies against phosphorylcholine but not with dietary fat in patients with rheumatoid arthritis: a cross-sectional study","volume":"11","author":"Elkan","year":"2009","journal-title":"Arthritis Res. Ther."},{"issue":"4","key":"10.1016\/j.biopha.2026.119772_bib31","doi-asserted-by":"crossref","first-page":"851","DOI":"10.5114\/aoms.2016.58928","article-title":"Obesity and inflammation: the linking mechanism and the complications","volume":"13","author":"Ellulu","year":"2017","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.biopha.2026.119772_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.117045","article-title":"Inhibition of JAK-STAT and NF-\u03baB signalling systems could be a novel therapeutic target against insulin resistance and type 2 diabetes","volume":"239","author":"Bako","year":"2019","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.biopha.2026.119772_bib33","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2022-002478","article-title":"The effect of tofacitinib on residual pain in patients with rheumatoid arthritis and psoriatic arthritis","volume":"8","author":"Dougados","year":"2022","journal-title":"RMD Open."},{"key":"10.1016\/j.biopha.2026.119772_bib34","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.biopha.2017.12.001","article-title":"Association of inflammatory mediators with pain perception","volume":"96","author":"Ronchetti","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"6","key":"10.1016\/j.biopha.2026.119772_bib35","first-page":"255","article-title":"An update on the role of (18)F-FDG-PET\/CT in major infectious and inflammatory diseases","volume":"9","author":"Kung","year":"2019","journal-title":"Am. J. Nucl. Med. Mol. Imaging"},{"issue":"5","key":"10.1016\/j.biopha.2026.119772_bib36","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1002\/ehf2.12915","article-title":"ZSF1 rat as animal model for HFpEF: Development of reduced diastolic function and skeletal muscle dysfunction","volume":"7","author":"Schauer","year":"2020","journal-title":"ESC Heart Fail."},{"issue":"3","key":"10.1016\/j.biopha.2026.119772_bib37","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jacc.2015.10.076","article-title":"Relative Wall Thickness and the Risk for Ventricular Tachyarrhythmias in Patients With Left Ventricular Dysfunction","volume":"67","author":"Biton","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119772_bib38","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/nrrheum.2015.171","article-title":"Cytokines in rheumatoid arthritis - shaping the immunological landscape","volume":"12","author":"McInnes","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119772_bib39","first-page":"318","article-title":"The mechanism of action of tofacitinib - an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis","volume":"34","author":"Hodge","year":"2016","journal-title":"Clin. Exp. Rheumatol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119772_bib40","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1159\/000530288","article-title":"Role of Interleukin-6 Family Cytokines in Organ Fibrosis","volume":"9","author":"Chen","year":"2023","journal-title":"Kidney Dis. (Basel)"},{"key":"10.1016\/j.biopha.2026.119772_bib41","article-title":"Pivotal Role of TGF-\u03b2\/Smad Signaling in Cardiac Fibrosis: Non-coding RNAs as Effectual Players","volume":"7","author":"Saadat","year":"2020","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.biopha.2026.119772_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.carpath.2024.107711","article-title":"Tocilizumab does not ameliorate inflammation-induced left ventricular dysfunction in a collagen-induced arthritis rat model","volume":"75","author":"Manilall","year":"2025","journal-title":"Cardiovasc. Pathol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119772_bib43","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.yjmcc.2008.05.006","article-title":"Role of resistin in cardiac contractility and hypertrophy","volume":"45","author":"Kim","year":"2008","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119772_bib44","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","article-title":"The JAK\/STAT signaling pathway: from bench to clinic","volume":"6","author":"Hu","year":"2021","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"23","key":"10.1016\/j.biopha.2026.119772_bib45","doi-asserted-by":"crossref","first-page":"19966","DOI":"10.1074\/jbc.M011759200","article-title":"Transforming growth factor-beta and ciliary neurotrophic factor synergistically induce vasoactive intestinal peptide gene expression through the cooperation of Smad, STAT, and AP-1 sites","volume":"276","author":"Pitts","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.biopha.2026.119772_bib46","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/iid3.155","article-title":"Complete Freund's adjuvant induces experimental autoimmune myocarditis by enhancing IL-6 production during initiation of the immune response","volume":"5","author":"Fontes","year":"2017","journal-title":"Immun. Inflamm. Dis."},{"issue":"4","key":"10.1016\/j.biopha.2026.119772_bib47","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.trsl.2014.05.001","article-title":"Obesity, metabolic dysfunction, and cardiac fibrosis: pathophysiological pathways, molecular mechanisms, and therapeutic opportunities","volume":"164","author":"Cavalera","year":"2014","journal-title":"Transl. Res."},{"issue":"10","key":"10.1016\/j.biopha.2026.119772_bib48","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1161\/01.RES.84.10.1127","article-title":"Mechanical stretch activates the JAK\/STAT pathway in rat cardiomyocytes","volume":"84","author":"Pan","year":"1999","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.biopha.2026.119772_bib49","doi-asserted-by":"crossref","first-page":"860","DOI":"10.4239\/wjd.v5.i6.860","article-title":"JA. Molecular mechanisms of AGE\/RAGE-mediated fibrosis in the diabetic heart","volume":"5","author":"Randive","year":"2014","journal-title":"World J. Diabetes"},{"issue":"4","key":"10.1016\/j.biopha.2026.119772_bib50","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1161\/HYPERTENSIONAHA.124.22845","article-title":"Role of Ciliary Neurotrophic Factor in Angiotensin II-Induced Hypertension","volume":"82","author":"Potthoff","year":"2025","journal-title":"Hypertension"},{"issue":"2S","key":"10.1016\/j.biopha.2026.119772_bib51","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/j.jaad.2023.05.049","article-title":"Janus kinase inhibitors for alopecia areata","volume":"89","author":"King","year":"2023","journal-title":"J. Am. Acad. Dermatol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226008085?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226008085?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T22:42:39Z","timestamp":1787179359000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226008085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":51,"alternative-id":["S0753332226008085"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119772","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating the cardiometabolic impact of Janus-kinase inhibition: An experimental analysis of Tofacitinib's therapeutic potential in a rodent model","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119772","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119772"}}